The quality of a registry based study depends on the quality of the data - without validation, it is questionable by Venermo, Maarit et al.
Eur J Vasc Endovasc Surg (2017) 53, 611e612EDITORIALThe quality of a registry based study depends on the quality
of the data e without validation, it is questionableIn 1972, the AHA Committee of Vascular Surgery published
a report that aimed to identify the resources required for
performance of high quality vascular surgery. One of the
recommendations in this report was that vascular surgeons
keep standardised and detailed records so that their work
may be readily judged by its results.1 Indeed, it is crucial in
vascular surgery to maintain a balance between the risks
related to surgery and those related to the patient’s dis-
ease. With borderline indications, such as asymptomatic
carotid stenosis and abdominal aortic aneurysms (AAAs)
close to 55 mm, the net beneﬁt can easily be negative if the
complication rates are above the standard. As already rec-
ommended almost 50 years ago, every vascular surgical unit
should know their complication rates, as should every
vascular surgeon. A vascular registry is the tool for con-
trolling the quality of the performance and allowing
continuous quality improvement.
The ﬁrst multi-surgeon computerised vascular registry
was established in Cleveland in 1975. In 1979, they reported
the results of the ﬁrst 8,824 procedures.2 The mortality rate
for all patients was 8.2% and for abdominal aortic re-
constructions 10.8%. The authors concluded that it is
possible to obtain a highly coordinated cooperative effort
from vascular surgeons working in discrete geographic
areas, and that the data gathered therein can be of value in
a variety of ways. In the late 1980s and 1990s, population
based national vascular registries were established in
several parts of Europe: in Sweden (1987), in Denmark and
Finland (1989), in Norway (1996), in the UK (1998), and,
later on in several other countries.
As the experience with vascular registries increased, the
validity of the registry data became an issue. In the ﬁrst
publication on the Swedvasc registry, a concern was
expressed that, in some hospitals, only 20% of the cases
were registered.3 The Finnvasc registry was validated in
1994 and 1996. The external validity was 81e86%, ranging
53e100% between the hospitals.4,5
Poor external validity raises the question of the procedures
that are not entered into the registry. Do they represent the
average patient population, or is there a selection mecha-
nism? There is some evidence that patientswho are forgotten
have worse outcomes compared with the registered ones.6,7DOIs of original article: http://dx.doi.org/10.1016/j.ejvs.2016.12.024,
http://dx.doi.org/10.1016/j.ejvs.2016.12.031.
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10.1016/j.ejvs.2017.03.017The operations most likely not registered are those per-
formed as emergencies, especially during the night.5 In the
latest validations of the Hungarian vascular registry and
Swedvasc, the external validity of carotid endarterectomies
and AAA reconstructions was extremely good, 94e109%.8,9
On a population base level, external validation can be per-
formed through comparison of the clinical registry with na-
tional administrative registries, and can be automated to
ensure continuous annual evaluation of the external validity.
Even if the external validity is 100%, poor internal validity
signiﬁcantly weakens the quality of the registry. There are
two aspects to internal validation: how correct are the
recorded data, and what is the proportion of missing data.
In the reports on internal validations, the procedural vari-
ables e such as the main indication, operation code,
anatomy e have been well recorded. However, pre-
operative risk factors, especially smoking, have had a high
proportion of missing data.3e5,9 Immediate surgical com-
plications and non-vascular re-operations have been highly
valid.6,9 Most crucial, however, is the validity of the follow-
up data. The collection of follow-up data may be difﬁcult, as
not all patients are able to revisit the hospital. Non-vascular
complications have more often been neglected than those
associated with surgery.6 Of the so called hard endpoints
after vascular surgery, death and amputation are also
registered in national mandatory registries. The possibility
to link the vascular registry to the national database
signiﬁcantly increases the validity of the registry. This is
currently the case at least in Swedvasc, the Danish vascular
registry Karbase and Husvasc (vascular registry of the Hel-
sinki University Hospital). This linkage allows for the exam-
ination of the long-term outcome. For example, after
elective endovascular aneurysm repair (EVAR), the in hos-
pital mortality is very low, but the risk of long-term RAAA
mortality persists even 10 years after the primary EVAR,
making long-term follow-up crucial.10
In the current issue of the Journal, two interesting studies
related to registries are reported.11,12 The ﬁrst reports the
results of AAA surgery during 1999e2010 in Germany,
including 39,500 AAA repairs.11 Themean age and proportion
of patients with ASA 3e4 increased over the study period.
The total in hospital mortality decreased from 3.1% to 2.3%,
and the use of EVAR increased from 17% to 63% of the pro-
cedures. The authors concluded that the in hospital patient
safety has improved, which is probably a result of the shift
towards the less invasivemethod of treatment. Furthermore,
the follow-up of the patients decreased from17 to 10 days, as
the data only include the in hospital outcome.The number of
612 Editorialparticipating hospitals varied annually between 79 and 137
during the study period, and the paper does not include in-
formation on the number of hospitals that participated in the
registry for the whole 12 year period. Unfortunately, neither
external nor internal validation was carried out, and the
proportion of missing data is not reported. Furthermore, no
ofﬁcial data on deaths were available. Despite their limita-
tions, the German data are valuable. It is a good example of
the power of a registry and its ability to accrue a substantial
database. It clearly shows the trends in demographics and the
choice of the treatment method, as well as in outcome.
Furthermore, the registry shows that half of the aneurysms
were<55 mm, and 25%<50 mm in diameter.When treating
these patients, the results should be extremely good, as the
risk of rupture is low. The long-term outcome of these pa-
tients would also be important.
The second study investigated the accuracy of the pe-
ripheral artery disease (PAD) diagnosis in the Danish na-
tional patient registry.12 It showed the vulnerability of
diagnosis data in a national administrative registry because
for one in three patients, the PAD diagnosis was not valid.
The authors concluded that their study stressed the
importance of the registry data validation. It emphasises
not only the importance of validation, but also of measures
taken to improve the validity. At the same time, the data
validity of the Danish vascular registry was found to be
good, and the authors concluded that the data could be
used without further validation. This ﬁnding is to be ex-
pected, as a vascular registry is for procedures performed
mostly because of PAD and used by vascular surgeons.
However, the statement that the data of the registry could
be used without further validation is only true when it
comes to the diagnosis, but not automatically so when it
comes to the other variables in the registry. The message of
the Danish study is important and should encourage deci-
sion makers and researchers involved with registries, which
are used for quality improvement decision making and
research, to carry out systematic continuous validation.
Whichmeasures can be taken to improve the validity of the
data? Regular external and internal validation are of impor-
tance, and annual external validation should be routine.
Continuous feedback to the operating surgeons on their
performance would undoubtedly improve the motivation to
enter cases into the registry, and thus validity.The VASCUNET
collaboration, which held its ﬁrst meeting during the Euro-
pean Society for Vascular Surgery (ESVS)meeting in Lisbon 20
years ago andhas been an ofﬁcialworking groupof ESVS since
2004, joins together 12 registries from Europe, Australia, and
New Zealand. The VASCUNET aims to improve the quality of
vascular surgery and patient safety using national clinical
registries.The VASCUNET group is well aware of the problems
related to incomplete data as a source of bias and in the end,
the risk of misleading messages. Therefore, a validation
project was initiated in 2013, aiming for validation of all
participating registries. So far, the validation has been
completed for the Hungarian and Swedish registries. The
group hopes to obtain resources to continue the validation
project.The editors of the Journal welcome the submission of
high quality data from national registries, as they contribute
to our scientiﬁc and clinical knowledge, and to continuous
improvement in the vascular surgical care that we offer to
our patients.REFERENCES
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